Phase II clinical studies of Cystic Fibrosis Transmembrane Conductance Triple Therapy, published recently in the NEJM, shows promise in patients with at least one copy of the F508del gene mutation, the most common cause of the illness.
Researchers at the UCD Charles Institute of Dermatology have developed a new gel that could one day drastically improve the quality of life of those living with the rare skin disease Epidermolysis Bullosa.
Our researchers were well represented among the winners at the 2018 UCD Conway Research Festival. Dr Ariane Watson, post-doctoral research fellow at Systems Biology Ireland took the Gold Medal. Medical Device Engineer and former School researcher, Dr Nicky Bertollo won first prize in the 2018 UCD Allergan Innovation Award competition with runner-up prize going to Dr Barbara Hughes from Prof Sabine Koelle's research group.
A ten year multi-centred Phase III randomised clinical trail has demonstrated that early prophylactic hypothermia compared with normothermia did not improve neurological outcomes at 6 months for patients with severe traumatic brain injury.
An international research team exploring the development of recombinant human Alkaline Phosphatase (recAP) for the treatment of inflammatory diseases published data on the recently completed STOP-AKI Phase II study of recAP in the treatment of sepsis-associated Acute Kidney Injury (AKI). The results were published in the Journal of the American Medical Association (JAMA) and were presented at both the European Society of Intensive Care Medicine in Paris and at the American Society of Nephrology Kidney Week in San Diego.
The UCD Ultrasound team in conjunction with the British Medical Ultrasound Society held a highly successful ultrasound study day on Sat 13th Oct 18 at UCD Health Sciences Centre. This fourth high profile study day was well received by the 200 delegates and demonstrates the ongoing need for continuous professional development activities in the field.
The National University of Ireland conferred an honorary degree of Doctor of Medicine on Prof Michael Earley, distinguished plastic and reconstruction surgeon and UCD Clinical Professor at the Children's University Hospital, Temple Street.
Copying the activity of molecules found naturally in the body could provide a new approach to treating vascular disease in diabetes, a new study involving our researchers at the UCD Diabetes Complications Research Centre has found.
Master Chisale has just completed his MSc by research on childhood pneumonia in the community in Malawi. He spoke about what he has learned when undertaking this research in UCD. While TB receives much attention nationally and globally, Master feels that childhood pneumonia is a neglected condition even though it is a very common in Malawi.
Information regarding the HSE application process for the 2019 Medical Intern training programme will be launched on the 19th October 2018. Please note that the expected closing date for applications is Tuesday 30th October 2018. Information is also available regarding the 2019 Intern Employment Eligibility Test.
CRDI invite expressions of interest for their online module entitled 'Case Studies in Drug Discovery & Development'. The module is free of charge for UCD postgraduate students and staff. Closing date: 18 Nov 18.